Immune Checkpoint Inhibitors Myocarditis: 1% Risk, 50% Fatal – UCSF Insights Other 3 Mins Read Immune checkpoint inhibitors myocarditis poses a serious threat in cancer care. These drugs fight tumors well. However, they can inflame…
2025 Breast Cancer Immunotherapy Trial Updates Breast Cancer 3 Mins Read On September 6, 2025, at the MOASC and ANCO Immuno-Oncology Symposium, Dr. Alexis LeVee, MD, from UCLA’s Division of Hematology/Oncology,…
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read Introduction to ASCO 2025 Lung Cancer Immunotherapy Updates At the MOASC/ANCO Immuno-Oncology Symposium held on September 6, 2025, in Marina…
